Partners4Access

Sophie Schmitz, Managing Partner of Partners4Access is to chair a panel discussion on rare diseases at the BioIndustry Association or BIA's event UK Bioscience Forum on October 18, 2018.

As part of its business expansion activities, Partners4Access' Sophie Schmitz will be attending industry group, BioIndustry Association (BIA)'s Summer Networking Reception on Thursday, July 12.

PARTNERS4ACCESS has announced its membership of the UK's leading biotechnology focused industry group, BioIndustry Association (BIA).

PARTNERS4ACCESS has announced the appointment of Alison Kneen as Vice President of International Operations to lead its rapidly expanding Market Access Orphan Drug Specialist team.

Free webinar will be held on Wednesday April 4 2018 at 17:00 GMT/1200 EST/9:00 PST.

New office accommodates higher headcount reflecting rapid growth for both companies

Partners4Access comment on the new Eurordis Position Paper on access to orphan drugs

Partners4Access (P4A), the specialists in orphan drug access, are launching a weekly newsletter focussing on key developments in the rare diseases and orphan drugs market access landscape.

Sophie Schmitz, Managing Partner of Partners4Access, the specialists in orphan drug access, is presenting at the 8th annual meeting of the World Orphan Drug Congress in Barcelona on November 15, 2017 on Gene Therapy.

Partners4Access (P4A) the specialists in orphan drug access, are presenting 3 posters at the International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) 20th European Congress in Glasgow from 4th to 8th November 2017.